Therefore, we postulated that the expression of csMVP would be beneficial for the generation and maintenance of CTCs in HCC patients, where CTCs are scarcely detected by anti-EpCAM antibody. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.